After court defeat, FDA shifts to regulating some drugs as devices
Regulatory NewsJeff Craven
Medical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJeff CravenMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy